CYCS and lung carcinoma: Moreover, VLX1570 upregulated cleaved PARP, cleaved caspase3 and cytosolic cytochrome c to induce apoptotic cell death in human lung cancer cells, indicating that VLX1570 can serve as an anti‐cancer drug for lung cancer.